# China NMPA Inspection - Guangxi Junning Baikang Biotechnology Co., Ltd. - September 30, 2018

Source: https://www.globalkeysolutions.net/records/china_inspection/guangxi-junning-baikang-biotechnology-co-ltd/feea37e4-5c5c-428f-8ab8-031d6ec69057/
Source feed: China

> China NMPA unannounced inspection for Guangxi Junning Baikang Biotechnology Co., Ltd. published September 30, 2018. An unannounced inspection of Guangxi Junning Baikang Biotechnology Co., Ltd. was conducted on June 28-29, 2018, by the Guangxi Zhuang Autonomous Regio

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Forwarding the results of the supervision and inspection of Guangxi Junning Baikang Biotechnology Co., Ltd.
- Company Name: Guangxi Junning Baikang Biotechnology Co., Ltd.
- Publication Date: 2018-09-30
- Product Type: Cosmetics
- Summary: An unannounced inspection of Guangxi Junning Baikang Biotechnology Co., Ltd. was conducted on June 28-29, 2018, by the Guangxi Zhuang Autonomous Region Food and Drug Evaluation and Inspection Center and Nanning Municipal Food and Drug Administration. The inspection, based on the "Key Points for Cosmetic Production License Inspection," identified two defects, including one serious violation. A primary finding was the company's long-term shutdown status; it had not officially commenced production since obtaining its license in November 2016.

Additional violations included a non-standardized batch production record for Rubus idaeus extract facial mask cream (batch 20170601), specifically noting an ingredient name discrepancy. Crucially, the inspection revealed expired raw materials, including Bletilla striata root extract and Rubus idaeus extract, and expired finished products, Rubus idaeus extract facial mask cream, which had not been handled or disposed of in a timely manner as required.

Consequently, the Nanning Municipal Food and Drug Administration was instructed to order the company to rectify these issues within a specified period. Guangxi Junning Baikang Biotechnology Co., Ltd. must report its rectification completion and is required to apply for a supervision and inspection from the Guangxi Zhuang Autonomous Region Food and Drug Administration before officially resuming any production activities. Production can only commence once compliance is confirmed by the inspection results.

Company: https://www.globalkeysolutions.net/companies/guangxi-junning-baikang-biotechnology-co-ltd/1892d03f-d856-4be7-9484-6225a8a3f5ca/